earnings
LG
NASDAQ · LGVN
Longeveron Inc. Common Stock
Healthcare · Biotechnology
$6.64
Up+$0.06 (+0.91%)
Updated Sep 11, 2026, 3:03 AM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 13.34M
- P/E ratio
- -0.54
- Dividend yield
- 0.00%
- 52-week range
- $0.49 – $8.70
- Volume
- 59.57K
- Avg. volume
- 453.73K
Price performance
LGVN price history
1M range · 20 trading sessions · Daily adjusted prices
LGVN closed at $6.64 after 20 trading sessions, up 851.83% for the selected period.
- Last close
- $6.64
- Period change
- +851.83%
- Period low
- $0.70
- Period high
- $8.45
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $6.52 | $6.7999 | $6.50 | $6.64 | 59.57K |
| Sep 9, 2026 | $6.58 | $6.75 | $6.51 | $6.58 | 29.57K |
| Sep 8, 2026 | $6.78 | $6.90 | $6.56 | $6.65 | 50.15K |
| Sep 4, 2026 | $6.54 | $6.88 | $6.53 | $6.81 | 41.24K |
| Sep 3, 2026 | $6.82 | $7.0399 | $6.55 | $6.58 | 43.96K |
| Sep 2, 2026 | $6.67 | $6.9482 | $6.6503 | $6.78 | 36.04K |
| Sep 1, 2026 | $6.86 | $7.0453 | $6.61 | $6.75 | 32.52K |
| Aug 31, 2026 | $6.75 | $7.299 | $6.51 | $6.90 | 106.93K |
| Aug 28, 2026 | $6.80 | $7.25 | $6.5501 | $6.72 | 79.78K |
| Aug 27, 2026 | $7.06 | $7.28 | $6.59 | $6.80 | 130.24K |
| Aug 26, 2026 | $6.86 | $7.40 | $6.76 | $7.033 | 66.6K |
| Aug 25, 2026 | $7.30 | $7.345 | $6.50 | $6.80 | 159.21K |
| Aug 24, 2026 | $8.50 | $8.70 | $8.049 | $8.378 | 93.96K |
| Aug 21, 2026 | $8.60 | $8.70 | $8.231 | $8.449 | 77.04K |
| Aug 20, 2026 | $0.84 | $0.89 | $0.8176 | $0.8282 | 618.69K |
| Aug 19, 2026 | $0.8115 | $0.88 | $0.80 | $0.8223 | 1.11M |
| Aug 18, 2026 | $0.80 | $0.83 | $0.7663 | $0.7872 | 504.92K |
| Aug 17, 2026 | $0.75 | $0.84 | $0.74 | $0.82 | 1.23M |
| Aug 14, 2026 | $0.7021 | $0.7549 | $0.7002 | $0.7399 | 298.77K |
| Aug 13, 2026 | $0.6701 | $0.7299 | $0.67 | $0.6976 | 534.67K |
Latest LGVN news
The latest Smart Investors Daily articles mentioning LGVN.
Stock researchResearch & News · Analysis
Loading stock research…

